Critical Care Therapies Pre and Post Heart Transplant and Their Impact: Analysis from The Pediatric Cardiac Critical Care Consortium

Shriprasad R Deshpande; Robert Gajarski; Bibhuti Das; Wenying Zhang; David Peng; Antonio Cabrera; Kurt Schumacher

doi:10.1016/j.healun.2024.05.009

Critical Care Therapies Pre and Post Heart Transplant and Their Impact: Analysis from The Pediatric Cardiac Critical Care Consortium

J Heart Lung Transplant. 2024 May 16:S1053-2498(24)01681-4. doi: 10.1016/j.healun.2024.05.009. Online ahead of print.

Authors

Shriprasad R Deshpande¹, Robert Gajarski², Bibhuti Das³, Wenying Zhang⁴, David Peng⁵, Antonio Cabrera⁶, Kurt Schumacher⁷

Affiliations

¹ Children's National Hospital, George Washington University, Washington, DC, USA. Electronic address: sdeshpan@childrensnational.org.
² Nationwide Children's Hospital, Columbus, OH, USA. Electronic address: robert.gajarski@nationwidechildrens.org.
³ Pediatric Cardiology, Baylor Scott and White Health, Temple, TX, USA. Electronic address: bibhuti.das@bswhealth.org.
⁴ University of Michigan, Ann Arbor, MI, USA. Electronic address: zwenying@med.umich.edu.
⁵ C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA. Electronic address: davepeng@med.umich.edu.
⁶ Primary Children's Hospital, Salt Lake City, UT. Electronic address: antonio.cabrera@hsc.utah.edu.
⁷ C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA. Electronic address: kurts@med.umich.edu.

PMID: 38762216
DOI: 10.1016/j.healun.2024.05.009

Abstract

Background: Few studies highlighting the critical care management of patients after heart HTx (HTx) have been published to date. This analysis provides a contemporary representation of critical care burden pre- and post-HTx, describes care differences based on pre-transplant diagnosis and outlines the impact of intensive care unit (ICU) therapies on outcomes.

Methods: Data from PC4 Collaborative Registry was analyzed for pediatric patients undergoing HTx between 08/2014-04/2022.

Results: 1877 HTx in 1857 patients were reported from 42 centers; 56.5% had congenital heart disease (CHD). Patients with CHD were younger, smaller, more likely male, White race, and publicly insured. Their pre-HTx ICU course was characterized by a higher need for catheterization, increased likelihood of inotropic support and mechanical ventilation with lower VAD rates. Their operative courses were significant for longer bypass and cross-clamp times. Postoperatively, CHD patients required more CPR and utilized more ICU therapies such as inotropes, ECMO and renal replacement. Those with CHD had a longer duration of ventilatory support (68.6 vs. 27.3 hours), total hospital stays (37.1 vs. 22.9 days) and higher hospital mortality (7.8% vs. 1.8%); all p<0.0001. Longer cardiopulmonary bypass and longer deep hypothermic circulatory arrest times and delayed sternal closure were independent risk factors for hospital mortality. Lastly, there was no association between total surgical volume for a center and outcomes but there was a significant relationship between center transplant volume and outcomes with higher volume centers demonstrating significantly lower mortality.

Conclusion: A diagnosis of CHD prior to HTx is associated with a greater use of ICU specific therapies compared non-CHD cohort. Operative factors, particularly in CHD patients, are independently associated with higher hospital mortality as was low transplant volume at the center. The study provides basis for further investigating ICU and operative factors that can be modified to improve transplant outcomes.

Keywords: HTx; cardiomyopathy; congenital heart disease; critical care; heart failure; mechanical circulatory support; outcomes; pediatrics; single ventricle.